Truveta Symposium 2024

July 10 | Bellevue, WA

Healthcare, public health, and life sciences Saving Lives with Data together

If you’d like to join us at future Truveta Symposium events, please contact us.

“Trusted real-world data has the potential to advance care, address health inequities, and accelerate science. It is an honor to bring together innovative industry leaders and renowned researchers across health systems, public health, and life science at Truveta Symposium this week. The collaborations established here have the potential to rapidly accelerate our shared mission of Saving Lives with Data.”

Terry Myerson

Chief Executive Officer & co-founder, Truveta

Agenda

Expand agenda

Our inspiration, the value of trust, and learning together	Terry Myerson, CEO and Co-founder, Truveta
Truveta product and research showcase
The transformative role of real-world data to democratize care	Aida Habtezion, MD, MSC, FRCPC, AGAF, Chief Medical Officer & Head, Worldwide Medical & Safety, Pfizer Inc. Rod Hochman, MD, CEO at Providence Moderator: Lisa Gurry, Chief Growth Officer and Co-founder at Truveta
Discordance in diagnosis time among patients with CKD: The effect of the CKD-EPI creatinine equation	Charlotte Baker, DrPH, MPH, Director of Epidemiology at Truveta
Lessons learned using Truveta’s large language models to extract seizure frequency from unstructured data	Sean Stern, MS, Director of Health Economics and Outcomes Research at SK Life Science, Inc.
Modernizing safety surveillance: Shared learnings across drugs and devices	Patrick Caubel, MD, Chief Safety Officer, Pfizer Inc. Michael Jaff, DO, FACC, Chief Medical Officer, Vice President, Clinical Affairs, Technology & Innovation, Peripheral Interventions, Boston Scientific Bram Zuckerman, MD, Director of the Office of Cardiovascular Devices, FDA CDRH Moderator: Ryan Ahern, MD, Chief Medical Officer and Co-founder at Truveta
Empowering researchers to deliver high-quality, real-world evidence with the most complete, timely, and clean EHR data	Michael Simonov, MD, Vice President of Product at Truveta
Contemporary treatment strategies in patients hospitalized for heart failure	Jimmy Zheng, MD, MS, Stanford University School of Medicine
Factors associated with discontinuation and reinitiation of GLP-1 RA	Tricia Rodriguez, PhD, MPH, Principal Applied Scientist at Truveta
Using RWD to understand utilization and disparities of drug eluting stents for the treatment of femoropopliteal artery disease	Abimbola Williams, MPH, MS, PhD, Senior Manager, HEOR, Boston Scientific
Industry collaboration to improve TAVR care gaps with RWD	Ty Gluckman, MD, MHA, FACC, FAHA, FASPC, Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence Health System Michael Mack, MD, Chair Cardiovascular Service Line, Chairman of the Board at Baylor Scott & White Research Institute, Dallas, TX, Baylor Scott & White Health and Heart Valve Collaboratory Pooja Sharma, Senior Vice President, Marketing and Strategy, Transcatheter Heart Valves, Edwards Lifesciences Moderator: Nick Stucky, MD, PhD, Vice President of Research at Truveta
Innovating with generative AI to transform healthcare	Jay Nanduri, Chief Technical Officer and Co-founder at Truveta

Expand agenda

Our inspiration, the value of trust, and learning together	Terry Myerson, CEO and Co-founder, Truveta
Truveta product and research showcase
The transformative role of real-world data to democratize care	Aida Habtezion, MD, MSC, FRCPC, AGAF, Chief Medical Officer & Head, Worldwide Medical & Safety, Pfizer Inc. Rod Hochman, MD, CEO at Providence Moderator: Lisa Gurry, Chief Growth Officer and Co-founder at Truveta
Discordance in diagnosis time among patients with CKD: The effect of the CKD-EPI creatinine equation	Charlotte Baker, DrPH, MPH, Director of Epidemiology at Truveta
Lessons learned using Truveta’s large language models to extract seizure frequency from unstructured data	Sean Stern, MS, Director of Health Economics and Outcomes Research at SK Life Science, Inc.
Modernizing safety surveillance: Shared learnings across drugs and devices	Patrick Caubel, MD, Chief Safety Officer, Pfizer Inc. Michael Jaff, DO, FACC, Chief Medical Officer, Vice President, Clinical Affairs, Technology & Innovation, Peripheral Interventions, Boston Scientific Bram Zuckerman, MD, Director of the Office of Cardiovascular Devices, FDA CDRH Moderator: Ryan Ahern, MD, Chief Medical Officer and Co-founder at Truveta
Empowering researchers to deliver high-quality, real-world evidence with the most complete, timely, and clean EHR data	Michael Simonov, MD, Vice President of Product at Truveta
Contemporary treatment strategies in patients hospitalized for heart failure	Jimmy Zheng, MD, MS, Stanford University School of Medicine
Factors associated with discontinuation and reinitiation of GLP-1 RA	Tricia Rodriguez, PhD, MPH, Principal Applied Scientist at Truveta
Using RWD to understand utilization and disparities of drug eluting stents for the treatment of femoropopliteal artery disease	Abimbola Williams, MPH, MS, PhD, Senior Manager, HEOR, Boston Scientific
Industry collaboration to improve TAVR care gaps with RWD	Ty Gluckman, MD, MHA, FACC, FAHA, FASPC, Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence Health System Michael Mack, MD, Chair Cardiovascular Service Line, Chairman of the Board at Baylor Scott & White Research Institute, Dallas, TX, Baylor Scott & White Health and Heart Valve Collaboratory Pooja Sharma, Senior Vice President, Marketing and Strategy, Transcatheter Heart Valves, Edwards Lifesciences Moderator: Nick Stucky, MD, PhD, Vice President of Research at Truveta
Innovating with generative AI to transform healthcare	Jay Nanduri, Chief Technical Officer and Co-founder at Truveta

“We have an opportunity to democratize care by connecting leaders across healthcare to learn, collaborate, and dream together. Truveta Symposium enables us to join forces and accelerate progress in critical areas like cardiovascular, oncology, and rare diseases to advance care for everyone.”

Rod Hochman, MD

President & CEO, Providence

Truveta Board Chair

Speakers

Charlotte Baker, DrPh, MPH

Director of Epidemiology, Truveta

Patrick Caubel, MD

Chief Safety Officer, Pfizer Inc.

Ty Gluckman, MD, MHA, FACC, FAHA, FASPC

Medical Director, Center for Cardiovascular Analytics, Research, and Data Science (CARDS), Providence Heart Institute, Providence Health System

Aida Habtezion

SVP, Chief Medical Officer and Head of Worldwide Medical and Safety, Pfizer

Rod Hochman, MD

Chief Executive Officer, Providence

Michael Jaff, DO, FACC

Chief Medical Officer, Vice President, Clinical Affairs, Technology & Innovation, Peripheral Interventions, Boston Scientific

Michael Mack, MD

Chair Cardiovascular Service Line, Chairman of the Board at Baylor Scott & White Research Institute, Dallas, TX, Baylor Scott & White Health and Heart Valve Collaboratory

Terry Myerson

Chief Executive Officer and co-founder, Truveta

Jay Nanduri

Chief Technical Officer and co-founder, Truveta

Pooja Sharma Rao

Senior Vice President, Marketing and Strategy, Transcatheter Heart Valves, Edwards Lifesciences

Tricia Rodriquez, PhD, MPH

Principal Applied Scientist, Truveta

Michael Simonov, MD

Vice President of Product, Truveta

Sean Stern, MS

Director of Health Economics and Outcomes Research, SK Life Science, Inc.

Abimbola Williams, MPH, MS, PhD

Senior Manager, HEOR, Boston Scientific

Jimmy Zheng, MD, MS

Stanford University School of Medicine

Bram Zuckerman, MD

Director of the Office of Cardiovascular Devices, FDA CDRH

“From my earliest discussions with Truveta, I saw the unique opportunity for leaders across healthcare to come together with a shared mission. Truveta Symposium creates this opportunity for us to come together, explore fascinating research, and discuss the opportunities and challenges facing us today with much hope for the future.”

Michael Jaff, DO, FACC

Chief Medical Officer, Vice President, Clinical Affairs, Technology & Innovation, Peripheral Interventions, Boston Scientific